Skip to content

外科合伙人

US · SGRY #2884 按市值排名 上市于 2015
14.61 -0.16 -1.08%
实时 - 追踪5344个代码 - 心跳于533秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

涨跌不一/平稳
  • 最近一期(2026/Q3)披露持股的机构数量增加了1家。
  • 机构持股总比例基本持平。

机构持股

机构持股比例
121.85% -0.03pp
机构数量
222 +1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund54.30%
VC/PE Fund39.17%
Hedge Fund23.12%
Public Company4.75%
Individual/Insider1.82%
Private Company0.27%
Government Pension Fund0.17%

主要股东 截至 2026-06-30

Bain Capital, LP 38.51% · 49.95M 股
Janus Henderson Group plc 10.70% · 13.88M 股
Pentwater Capital Management LP 8.97% · 11.63M 股
UBS Asset Management 7.74% · 10.04M 股
BlackRock 4.81% · 6.24M 股
King Street Capital Management, L.P. 4.67% · 6.06M 股
T. Rowe Price Group, Inc. 4.66% · 6.04M 股
Dimensional Fund Advisors 3.81% · 4.94M 股
Vanguard Capital Management, LLC 3.10% · 4.02M 股
ClearBridge Investments, LLC 2.95% · 3.82M 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 24次买入 · 23次卖出

姓名职务持股比例
Bain Capital, LP -- 38.51%
J. Evans Chief Executive Officer 0.71%
Jennifer Baldock Executive VP and Chief Administrative & Development Officer 0.25%
David Doherty Chief Financial Officer 0.17%
W. Webb Senior Vice President of Central Region 0.10%
Justin Oppenheimer COO & National Group President 0.09%
Harrison Bane President of American Group 0.09%
Marissa Brittenham Chief Strategy Officer 0.07%
William Turner Independent Director 0.07%
Danielle Burkhalter Chief Human Resources Officer 0.06%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-08-17 Teresa DeLuca Independent Director Open Market Acquisition +11,250 $14.33
2026-06-17 Blair Hendrix Director Other Acquisition +34,364 $14.55
2026-06-04 Clifford Adlerz Director Other Acquisition +11,670 $13.71
2026-06-04 Lloyd Dean Independent Director Other Acquisition +11,670 $13.71
2026-06-04 William Turner Independent Director Other Acquisition +11,670 $13.71
2026-06-04 Teresa DeLuca Independent Director Other Acquisition +11,670 $13.71
2026-06-04 John Deane Independent Director Other Acquisition +11,670 $13.71
2026-06-04 Laura Forese Independent Director Other Acquisition +11,670 $13.71
2026-03-15 David Doherty Chief Financial Officer Open Market Disposition -8,867 $12.50
2026-03-15 J. Evans Chief Executive Officer Open Market Disposition -20,400 $12.47
2026-03-12 Marissa Brittenham Chief Strategy Officer Open Market Disposition -3,657 $12.54
2026-03-12 Danielle Burkhalter Chief Human Resources Officer Open Market Disposition -3,469 $12.83
2026-03-11 Jennifer Baldock Executive VP and Chief Administrative & Development Officer Open Market Disposition -5,798 $13.17
2026-03-05 David Doherty Chief Financial Officer Other Acquisition +141,743 $14.11
2026-03-05 J. Evans Chief Executive Officer Other Acquisition +278,106 $14.11
2026-03-05 Jennifer Baldock Executive VP and Chief Administrative & Development Officer Open Market Disposition -10,082 $13.70
2026-03-05 Marissa Brittenham Chief Strategy Officer Other Acquisition +43,230 $14.11
2026-03-05 Danielle Burkhalter Chief Human Resources Officer Private Disposition -7,736 $13.60
2026-03-05 W. Webb Senior Vice President of Central Region Other Acquisition +31,892 $14.11
2026-03-04 David Doherty Chief Financial Officer Open Market Disposition -14,574 $13.84

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

外科合伙人 讨论区 0 条评论

发表评论